Fidelity International’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-10,531
Closed -$1.94M 1134
2021
Q1
$1.94M Hold
10,531
﹤0.01% 681
2020
Q4
$2.88M Sell
10,531
-7,197
-41% -$1.81M ﹤0.01% 593
2020
Q3
$4.15M Buy
+17,728
New +$4.45M 0.01% 549

Other funds holding FRLN

Fidelity International's FRLN Position: Q2 2021 in Review

Fidelity International sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q2 2021, closing a stake of 10,531 shares — an estimated $1.94M sold.

Fidelity International first reported a position in FRLN in Q3 2020 and held it in 3 quarters. The position peaked at $4.15M in Q3 2020. 16 funds tracked by Wall St. Rank hold FRLN as of Q2 2021.

  • Fidelity International reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Fidelity International sold 10,531 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q2 2021, an estimated $1.94M.
  • Fidelity International first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2020 and held it in 3 quarters.
  • Fidelity International's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $4.15M in Q3 2020.
  • 16 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q2 2021.

Based on Fidelity International's 13F filing for Q2 2021, filed 13 Aug 2021.